Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 9

1.

Using genetic drug-target networks to develop new drug hypotheses for major depressive disorder.

Gaspar HA, Gerring Z, Hübel C; Major Depressive Disorder Working Group of the Psychiatric Genomics Consortium, Middeldorp CM, Derks EM, Breen G.

Transl Psychiatry. 2019 Mar 15;9(1):117. doi: 10.1038/s41398-019-0451-4.

PMID:
30877270
2.

GWAS of lifetime cannabis use reveals new risk loci, genetic overlap with psychiatric traits, and a causal influence of schizophrenia.

Pasman JA, Verweij KJH, Gerring Z, Stringer S, Sanchez-Roige S, Treur JL, Abdellaoui A, Nivard MG, Baselmans BML, Ong JS, Ip HF, van der Zee MD, Bartels M, Day FR, Fontanillas P, Elson SL; 23andMe Research Team, de Wit H, Davis LK, MacKillop J; Substance Use Disorders Working Group of the Psychiatric Genomics Consortium; International Cannabis Consortium, Derringer JL, Branje SJT, Hartman CA, Heath AC, van Lier PAC, Madden PAF, Mägi R, Meeus W, Montgomery GW, Oldehinkel AJ, Pausova Z, Ramos-Quiroga JA, Paus T, Ribases M, Kaprio J, Boks MPM, Bell JT, Spector TD, Gelernter J, Boomsma DI, Martin NG, MacGregor S, Perry JRB, Palmer AA, Posthuma D, Munafò MR, Gillespie NA, Derks EM, Vink JM.

Nat Neurosci. 2018 Sep;21(9):1161-1170. doi: 10.1038/s41593-018-0206-1. Epub 2018 Aug 27.

3.

Genome-wide DNA methylation profiling in whole blood reveals epigenetic signatures associated with migraine.

Gerring ZF, McRae AF, Montgomery GW, Nyholt DR.

BMC Genomics. 2018 Jan 22;19(1):69. doi: 10.1186/s12864-018-4450-2.

4.

RE: Six novel rare non-synonymous mutations for migraine without aura identified by exome sequencing.

Albury CL, Gerring ZF, Griffiths LR, Nyholt DR, Rodriguez-Acevedo AJ.

J Neurogenet. 2017 Dec;31(4):320-321. doi: 10.1080/01677063.2017.1382490. Epub 2017 Nov 6. No abstract available. Erratum in: J Neurogenet. 2017 Dec;31(4):i.

PMID:
29105529
5.

Genome-wide analysis of blood gene expression in migraine implicates immune-inflammatory pathways.

Gerring ZF, Powell JE, Montgomery GW, Nyholt DR.

Cephalalgia. 2018 Feb;38(2):292-303. doi: 10.1177/0333102416686769. Epub 2017 Jan 6.

PMID:
28058943
6.

Can we predict those at higher risk for migraine?

Gerring ZF, Nyholt DR.

Per Med. 2016 May;13(3):205-207. doi: 10.2217/pme-2016-0015. Epub 2016 Apr 6. No abstract available.

PMID:
29767612
7.

Blood gene expression studies in migraine: Potential and caveats.

Gerring Z, Rodriguez-Acevedo AJ, Powell JE, Griffiths LR, Montgomery GW, Nyholt DR.

Cephalalgia. 2016 Jun;36(7):669-78. doi: 10.1177/0333102416628463. Epub 2016 Feb 9. Review.

PMID:
26862113
8.

Phosphohistone H3 outperforms Ki67 as a marker of outcome for breast cancer patients.

Gerring Z, Pearson JF, Morrin HR, Robinson BA, Harris GC, Walker LC.

Histopathology. 2015 Oct;67(4):538-47. doi: 10.1111/his.12678. Epub 2015 Mar 31.

PMID:
25728258
9.

School nursing in New Zealand: a study of services.

Buckley S, Gerring Z, Cumming J, Mason D, McDonald J, Churchward M.

Policy Polit Nurs Pract. 2012 Feb;13(1):45-53. doi: 10.1177/1527154412438919. Epub 2012 Mar 27.

PMID:
22454218

Supplemental Content

Loading ...
Support Center